Lucintel Forecasts The Global Skin Cancer Diagnostics & Therapeutics Market To Reach $18 Billion By 2030

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to a market report by Lucintel, the future of the global skin cancer diagnostics & therapeutics market looks promising with opportunities in the diagnosis and therapeutic markets. The global skin cancer diagnostics & therapeutics market is expected to reach an estimated $18 billion by 2030 from $14 billion in 2024, at a CAGR of 5% from 2024 to 2030. The major drivers for this market are increasing government initiatives for early detection and skin cancer treatment, rising research and development activities for skin cancer diagnostics and therapeutics, and growing incidences and rising awareness of skin cancer globally.
A more than 150-page report to understand trends, opportunity and forecast in global skin cancer diagnostics & therapeutics market to 2030 by cancer type (melanoma and non-melanoma), type (diagnosis, therapeutics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that non-melanoma is expected to witness higher growth over the forecast period due to growing the increasing cases of non-melanoma as these skin cancer starts ...
... in skin cells and a cancerous (malignant) growth is a group of cancer cells that can grow into and destroy nearby tissue. it can also spread (metastasize) to other parts of the body, but this is rare with non-melanoma skin cancer.
Within this market, therapeutic will remain the largest segment.
Download sample by clicking on skin cancer diagnostics & therapeutics market.
North America will remain the largest segment over the forecast period due to the growing prevalence and incidence of skin cancers in this region.
Ab Science, Abbott Laboratories, Amgen, Astrazeneca, Bristol-Myers Squibb, Castle Biosciences, Daiichi Sankyo, Damae Medical, Dermtech, F. Hoffmann-La Roche are the major suppliers in the skin cancer diagnostics & therapeutics market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hazardous Drug Compounding System Market
Intelligent Outbound Call Center Market
Omnichannel Call Center Service Market
Portable Tablet Hardness Tester Market
Retinal Disease Therapy Option Market